These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Lamotrigine administration in panic disorder with agoraphobia. Masdrakis VG; Papadimitriou GN; Oulis P Clin Neuropharmacol; 2010 May; 33(3):126-8. PubMed ID: 20502131 [TBL] [Abstract][Full Text] [Related]
14. Pramipexole for the treatment of uremic restless legs in patients undergoing hemodialysis. Miranda M; Kagi M; Fabres L; Aguilera L; Alvo M; Elgueta L; Erazo S; Venegas P Neurology; 2004 Mar; 62(5):831-2. PubMed ID: 15007148 [No Abstract] [Full Text] [Related]
15. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test. Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263 [TBL] [Abstract][Full Text] [Related]
16. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors. Siuciak JA; Fujiwara RA Psychopharmacology (Berl); 2004 Sep; 175(2):163-9. PubMed ID: 14985923 [TBL] [Abstract][Full Text] [Related]
17. Ropinirole and pramipexole, the new agonists. Hobson DE; Pourcher E; Martin WR Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S27-33. PubMed ID: 10451757 [TBL] [Abstract][Full Text] [Related]
18. Introduction: pramipexole: a novel dopamine agonist for the treatment of Parkinson's disease. de Yebenes JG Eur J Neurol; 2000 May; 7 Suppl 1():1-2. PubMed ID: 11054151 [No Abstract] [Full Text] [Related]
19. The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia. Bakish D J Clin Psychopharmacol; 1994 Feb; 14(1):74-5. PubMed ID: 8151007 [No Abstract] [Full Text] [Related]